Sheri L Koshman Selected Research

Sheri L Koshman Research Topics

8	Heart Failure 12/2021 - 01/2015
4	Acute Coronary Syndrome 01/2024 - 01/2012
4	Atrial Fibrillation 12/2023 - 03/2012
4	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 05/2016
3	Hemorrhage 01/2020 - 05/2016
3	Myocardial Infarction 01/2020 - 05/2016
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2020
2	Unstable Angina 01/2020 - 07/2017
2	Stroke (Strokes) 07/2017 - 07/2016
1	Cardiotoxicity 01/2022
1	Inflammation (Inflammations) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Amyloidosis 01/2020
1	Transthyretin-Related Hereditary Amyloidosis 01/2020
1	Dyspnea (Shortness of Breath) 01/2020
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Venous Thromboembolism 01/2020
1	Death (Near-Death Experience) 11/2017
1	Hypertension (High Blood Pressure) 07/2016
1	Hypersensitivity (Allergy) 07/2016
1	Diabetes Mellitus 07/2016
1	Anemia 01/2015
1	Dyslipidemias (Dyslipidemia) 03/2012
1	Postpericardiotomy Syndrome 12/2009
1	Pericarditis 12/2009
1	Drug-Related Side Effects and Adverse Reactions 06/2009
1	Out-of-Hospital Cardiac Arrest 10/2005
1	Heart Arrest (Cardiac Arrest) 10/2005

4	AnticoagulantsIBA 12/2023 - 07/2016
3	Warfarin (Coumadin)FDA LinkGeneric 03/2023 - 05/2016
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2020 - 12/2009
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2020 - 01/2015
2	Clopidogrel (Plavix)FDA Link 01/2020 - 07/2016
2	omega-Chloroacetophenone (Mace)IBA 01/2020 - 01/2020
2	Neprilysin (Neutral Endopeptidase)IBA 01/2020 - 01/2015
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 05/2022
1	human ERBB2 proteinIBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	dapagliflozinIBA 01/2020
1	tafamidisIBA 01/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020
1	TicagrelorIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Prealbumin (Transthyretin)IBA 01/2020
1	SodiumIBA 01/2020
1	empagliflozinIBA 07/2017
1	semaglutideIBA 07/2017
1	Liraglutide FDA Link 07/2017
1	lixisenatideIBA 07/2017
1	Dipeptidyl-Peptidase IV InhibitorsIBA 07/2017
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 05/2016
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2016
1	Mineralocorticoid Receptor AntagonistsIBA 01/2015
1	Natriuretic PeptidesIBA 01/2015
1	oxidized low density lipoproteinIBA 03/2012
1	Dabigatran FDA Link 03/2012
1	LipidsIBA 03/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012
1	Colchicine FDA LinkGeneric 12/2009
1	Vasopressins (Vasopressin)IBA 10/2005
1	Epinephrine (Adrenaline)FDA LinkGeneric 10/2005

9	Therapeutics 12/2021 - 06/2009
4	Transjugular Intrahepatic Portasystemic Shunt 01/2021 - 01/2015
3	Percutaneous Coronary Intervention 01/2022 - 07/2016
2	Stents 01/2020 - 07/2016
1	Aftercare (After-Treatment) 01/2024
1	Transcatheter Aortic Valve Replacement 07/2016
1	Secondary Prevention 12/2009